Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 6.58 USD -1.05%
Market Cap: 243.7m USD

Lifecore Biomedical Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lifecore Biomedical Inc
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Lifecore Biomedical Inc
NASDAQ:LFCR
Total Other Income
$18.3m
CAGR 3-Years
293%
CAGR 5-Years
N/A
CAGR 10-Years
17%
Hershey Co
NYSE:HSY
Total Other Income
-$258.6m
CAGR 3-Years
-265%
CAGR 5-Years
-66%
CAGR 10-Years
-58%
General Mills Inc
NYSE:GIS
Total Other Income
$66.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kellogg Co
NYSE:K
Total Other Income
-$13m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kraft Heinz Co
NASDAQ:KHC
Total Other Income
$121m
CAGR 3-Years
-18%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Mondelez International Inc
NASDAQ:MDLZ
Total Other Income
$424m
CAGR 3-Years
25%
CAGR 5-Years
16%
CAGR 10-Years
N/A

Lifecore Biomedical Inc
Glance View

Market Cap
243.3m USD
Industry
Food Products

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.

LFCR Intrinsic Value
10.02 USD
Undervaluation 34%
Intrinsic Value
Price

See Also

What is Lifecore Biomedical Inc's Total Other Income?
Total Other Income
18.3m USD

Based on the financial report for Nov 24, 2024, Lifecore Biomedical Inc's Total Other Income amounts to 18.3m USD.

What is Lifecore Biomedical Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
17%

Over the last year, the Total Other Income growth was -6%. The average annual Total Other Income growth rates for Lifecore Biomedical Inc have been 293% over the past three years , and 17% over the past ten years .

Back to Top